NASA Administrator Jared Isaacman said the agency plans an uncrewed Starliner mission to the ISS in 2027, followed by a crewed flight by 2028.
A report on NASA's commercial low-Earth-orbit destinations program quotes a Boeing representative discussing pricing conversations with CLD suppliers.
A report from NASA Breaking News sets out the main available details, with claims kept attributed to their sources.
A report from CNBC — Top News sets out the main available details, with claims kept attributed to their sources.
The malfunction could affect the aircraft's automated navigation system and potentially create a safety risk during landing, according to the Wall Street Journal.
The manufacturer identified an issue that can affect automated vertical navigation after a missed approach.
U.S. bond yields rose sharply Wednesday as stocks broadly declined, though Boeing shares moved higher against the wider market pullback.
The agencies will discuss the spacecraft's progress and plans for regular crew flights to the International Space Station.
A report from CNBC — Top News sets out the main available details, with claims kept attributed to their sources.
The flag carrier's latest order follows its largest-ever aircraft purchase placed earlier this year.
The agreement, overseen by Turkish President Recep Tayyip Erdogan, is part of the airline's long-term growth strategy.
Madagascar's courts have opened trial proceedings against 33 defendants linked to the discovery in Iran of five Boeing 777 aircraft bearing Malagasy registration marks.
U.S. equities rebounded after declines tied to Federal Reserve news, while CNBC's Investing Club also addressed ongoing challenges at Boeing.
Kelly Ortberg points to wing production bottleneck at Renton, Washington, factory as company works on a fix.
Report says space agency plans more missions for the capsule and will help certify a new rocket to keep it flying, despite earlier setbacks.
Union officials said the tentative deal was struck on Friday, though full details have not yet been released.
Eli Lilly stock rises while broader pharmaceutical sector declines in afternoon trading.